One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-111951
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 11 |
Affiliation: Medical College of Wisconsin, Fred Hutch Cancer Center, West Virginia University, Baylor University Medical Center, Ochsner Medical Center, OSF Saint Francis Medical Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, Cornell University, University of Louisville, Mayo Clinic, Swedish Medical Center, Duke University, Actinium Pharmaceuticals (United States), Columbia University Irving Medical CenterA Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 µci/Kg/Dose
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
